0001127602-19-011378.txt : 20190314 0001127602-19-011378.hdr.sgml : 20190314 20190314170735 ACCESSION NUMBER: 0001127602-19-011378 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190312 FILED AS OF DATE: 20190314 DATE AS OF CHANGE: 20190314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abdel-Malek Aiman CENTRAL INDEX KEY: 0001670040 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 19681848 MAIL ADDRESS: STREET 1: C/O INSULET CORPORATION STREET 2: 600 TECHNOLOGY PARK DRIVE, SUITE 200 CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-03-12 0001145197 INSULET CORP PODD 0001670040 Abdel-Malek Aiman C/O INSULET CORPORATION 100 NAGOG PARK ACTON MA 01720 1 EVP & Chief Technology Officer Common Stock 2019-03-12 4 M 0 19915 31.20 A 43907 D Common Stock 2019-03-12 4 M 0 5686 46.22 A 49593 D Common Stock 2019-03-12 4 M 0 1748 74.50 A 51341 D Common Stock 2019-03-12 4 S 0 27349 94.0295 D 23992 D Employee Stock Option (Right to Buy) 31.20 2019-03-12 4 M 0 19915 0 D 2026-03-28 Common Stock 19915 11967 D Employee Stock Option (Right to Buy) 46.22 2019-03-12 4 M 0 5686 0 D 2027-02-22 Common Stock 5686 5686 D Employee Stock Option (Right to Buy) 74.50 2019-03-12 4 M 0 1748 0 D 2028-02-14 Common Stock 1748 5247 D Includes 4,674 restricted stock units granted on March 28, 2016, which vest on March 28, 2019; 4,006 performance share units granted on March 28, 2016, which vest on March 28, 2019; 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $93.67 to $94.53. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. /s/ David Colleran, attorney-in-fact 2019-03-14